UK NHS, Industry Agreement On Artificial Pancreas Pricing Clears Way For Takeoff
Executive Summary
The UK’s national rollout of hybrid closed loop (HCL) technologies marks NHS England as the global leader in providing equitable and fair access to next-generation diabetes management, Partha Kar, type 1 diabetes and technology lead, told Medtech Insight. Market leader Medtronic offers perspective.